During the first month of vaccination, the Center received 689 report forms on adverse events following immunization (AEFI). The AEFI rate after almost 200 thousand administered doses of Covishield was 0,35%. The vast majority of cases (92, 8%) were non-serious adverse reactions.
Common manifestations include:
- administration site disorders (65,73%);
- musculoskeletal disorders (12,98%);
- neurological disorders (11,96%).
See the visualization for details.
